RIGHTS ISSUE WITH WARRANTS APPROVED! TIME TO FLY SOON?!
Seasoned investors that are familiar with corporate exercise would definitely be no stranger to rights issue. But for new investors, rights issue is commonly a way for listed companies to raise additional capital from shareholders – sometimes it also comes with a sweetener, warrant.
How impactful is warrant on the share price? Just take a look at these few companies share price after bonus issue or rights issue that comes with warrant.
Of course, there are plenty more examples where companies that issued free warrants might spike up. But why is that so?
Warrant – as a financial derivative which carries the ability to allow its holder to have the right but not obligated to convert it into mother share, often seen as an opportunity to arbitrage. It is an advanced technique that often used by seasoned investors but to put it in plain English, some big holders of warrant might “push” the mother share price to increase the attractiveness in warrant due to the conversion gap and the arbitrage opportunity.
However, Kanger International Berhad (KLSE: KANGER) – the recent darling of vaccine theme play had finally gotten their approval from Bursa for the rights issue that comes along with the warrant sweetener.
How do we know for sure KANGER might fly anytime soon? To answer this question, we must study the price movement pattern of the company.
As you can see, the company had a downturn in share price and momentum since the vaccine market was slammed hard by the government. But what we could tell from the chart is that there is an attempt to breakout on 28th May 2021. What could possibly trigger the buying momentum?
After going around several forums and platforms, I noticed that there are already rumours being spread on KANGER’s rights issue shall be approved at anytime soon. Perhaps this spiked the buying interest – but unfortunately, the company only announced the good news on yesterday, hence investors might have got in too early.
Nevertheless, with the approval for warrants, I’m sure that KANGER will continue to fly once operator had finished the accumulation of shares – which they already did since 2019 to 2020 and washed most new investors off KANGER by now.
From technical analysis + corporate news standpoint, we could begin our execution on the trade. The for-sure support level for the company is at 6.0 cents level. And the most recent resistance of the company would be at 11.5 cents and 15.0 cents, respectively. This represents a potential downside risk of 20.0%, and for the upside, that would be between 53.3% and 100.0%, representing a risk-to-reward ratio of 2.6 times to 5.0 times!
On the back of years of my trading experience, KANGER will definitely ride on the positive news and depart soon. Do not miss out the ride on this company!
Panjang cerita tidak guna, apa lannnn ko cerita pun dah setahun dah berlalu, dari 33 sen tinggal 6 sen je, ko main la sama sendiri kasi syiok bontot sendiri. New comer, baru2 main saham please avoid to be trapped in this counter
@BilisMasin. The issue price of the RI shares has been fixed @ 6 sen per share.
Thank you. ........
On behalf of the Board, UOB Kay Hian wishes to announce that the Board had on 26 April 2021 ("Price-Fixing Date") resolved to fix the issue price of the Rights Shares at RM0.06 per Rights Share ("Issue Price").
ikan bilis our hope over you.... help to bring down to 0.04... if u can lar.. if not 0.055 also good jo.... if not u goreng sotong sendiri.... what lar take ppl money but cannot manage to bring to price to lowest... lang par mulut... lang par hand... tak guna punya org...
Madcow. True bro. Some true investors are also waiting to buy low. Like MZM says RI price is 0.06. I am not afraid to throw my remaining bullets in. My beliefs- either pn7 or have to move up. What says all my brothers
jangan throw apa pe, reject je RI tu kat 28/06 egm la kalau harga tebu kena main panda, sis, esos, sos cili, sos napra, scamla biar panda jawab strategy short term ya
Apa2 pun new comer, retailer n investor, please avoid this type of counter, sayangi duit anda. Biar kan promoter, operator dan sindiket main sama sendiri, biar dia orang syiok sama sendiri, ini cha ya nun alip punya kerja
Setakat ini, katanya, Malaysia hanya meluluskan penggunaan vaksin Pfizer, Sinovac dan AstraZeneca sedangkan Pertubuhan Kesihatan Dunia (WHO) telah menyenaraikan Johnson & Johnson, Moderna dan Sinopharm untuk kegunaan kecemasan di seluruh dunia.- Hishammuddin Hussein
MZM2511 dah dua menteri cuba up vaksin sinopharm dll...hasilnya belum ada dampak positif yg ketara....tema vaksin belum menjelma ka ni....hari ni tema glove
Nampak sangat ramai yang gamble on this counter . I remember a professor or someone first talk on a tv news that Sinopharm will be brought in by Kanger ( sometimes almost 8 months ago ? ) and lately so many in news , even politician pushing for its approval after WHO approve it . But nothing happened. Probably connection not strong. I guess to obtain approval beside the intended importer , the origin manufacturer must also need to provide approval and some agency /distributor authority ???
@JK22 ... the origin manufacturer must also need to provide approval and some agency /distributor authority ???
-------------- Actually the agreement for Sinopharm Covid-19 vaccine distributorship being signed with the Sinopharm Group Hunan Changde Medical Co. Ltd., which is Sinopharm Group subsidiary.
-------------- Sinopharm Hunan Changde shall designate and appoint Kanger as the distributor of Sinopharm Hunan Changde’s Products in Malaysia whereas Kanger shall promote and market the Products for Sinopharm Hunan Changde in Malaysia.
The Parties unanimously agree that a long-term collaborative relationship shall be established in accordance with the terms and conditions of this Agreement. In respect of the specific product category,products’ price, purchase price and payment method, both Parties shall enter into a separate distribution agreement on the basis and in accordance with the terms of this Agreement.
This Agreement shall take effect for a period of three (3) years effective from 25 September 2020 until 24 September 2023 in accordance with the terms therein.
Do not influence by haters or fake analysts in I3 forum, they all appear everywhere. At the end of the day when the price up, they will hide in the cave. Look at SerbaDnk, every day multiple pages occupied by haters in the forum, PN17 la, Delisted la, going t bankrupt la, 0.09send coming soon la and so many negative fake stories created to create fear to genuine investor be it, retailers or big shareholder. These haters normally do not have a single penny in this company either. Do your own judgment, it is your money.
Today Serbadnk strongly rebound and these haters hide in the cave.
nowadays prices can go lower low.. look at focus... from RM2 can go deep down 0.040... con companies can do pp n consolidation to push existing holders to penthouses...
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
BilisMasin
965 posts
Posted by BilisMasin > 2021-06-11 12:07 | Report Abuse
Game yang sama guys
Mana pergi hilang 500,000 lot buy Q kat 0.065
Hahahahahahaha